DOSIsoft, leading provider of advanced software solutions for Radiation Oncology and Nuclear Medicine, is pleased to announce it has received on March 7th, 2019, from the US Food and Drug Administration (FDA), the 510(k) clearance to market PLANET® Onco Dose software, for its Oncology and Yttrium-90 microsphere SIRT 3D Dosimetry components.
An integrated imaging and dosimetry platform dedicated to Molecular Imaging & Molecular Radiotherapy Dosimetry
PLANET® Onco Dose is a comprehensive software platform dedicated to medical diagnosis aid, therapy response assessment aid, contouring for radiotherapy and internal dosimetry computation, using molecular imaging modalities.
Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.
PLANET® Onco Dose is a modular software suite composed of two main elements:
- PLANET® Onco: The Oncology module with core System features, comprehensive reviewing of multimodal molecular image series (CT, MRI, PET, SPECT), fusion and registration, automatic and semi-automatic contouring of regions of interest, tumor segmentation, quantification, tumoral activity monitoring, therapy response assessment;
- PLANET® Dose: The Dosimetry module including 3D personalized voxel-based internal dosimetry computation dedicated to Molecular Radiotherapy (MRT)
PLANET® Onco provides advanced tools to display, co-register (including deformable registration), compute Standardized Uptake Value and import / export results (contours and quantification results) to / from Treatment Planning Systems and PACS devices for assessment, treatment planning and response of patients undergoing a course of oncology treatments.
A personalized 3D dosimetry solution for 90Yttrium-based Selective Internal Radiation Therapy
Leveraging its long-term experience, DOSIsoft has transferred its External Radiation Therapy advanced software technology to Nuclear Medicine and Molecular Radiotherapy. CE marked since March 2016, PLANET® Onco Dose is the first fully integrated imaging and personalized 3D dosimetry platform for radionuclide-based therapies.
PLANET® Onco Dose is intended to assist the user in the diagnosis, quantification and verification of radiation doses received by tissues as a result of administering permanent Yttrium-90 (90Y) microsphere implants, as well as in therapy response follow-up.
PLANET® Onco Dose provides tools for post-treatment absorbed dose calculation and evaluation on PET and SPECT images. The following functions are available to allow dose calculations for patients after they have received a treatment using permanent Yttrium-90 microspheres: